You are here: Industry Insights > portfolio

News List

Sartorius Acquires Stake in ALS Expanding Bioanalytics Portfolio contractpharma
December 17, 2021
Gains solutions for the automated analysis, selection and isolation of cells.
CSafe Global Acquires Softbox Systems contractpharma
December 16, 2021
Creates a global leader in temperature-controlled shipping solutions.
Qiming's Portfolio Company CANbridge Pharmaceuticals Lists on Main Board of HKEx prnasia
December 13, 2021
Qiming Venture Partners' portfolio company CANbridge Pharmaceuticals (SEHK: 1228), a leading China-based global rare disease-focused biopharmaceutical company, today listed on the main board of Hong Kong, S.A.R., China Stock Exchange.
Lonza signs five-year collaboration deal with VC firm Bioqube to speed up portfolio companies’ development and manufacturing CPhIonline
December 01, 2021
The offering will accelerate timelines for the development and manufacturing of molecules and disruptive technologies.
Mentice Expands Coronary Product Portfolio with the Introduction of Coronary Intermediate Software prnasia
March 16, 2020
Designed by clinical experts, the software helps improve user proficiency by incorporating an extensive library of cases that present various degrees of difficulty.
PSE plans to become part of Siemens biospectrumasia
September 18, 2019
Costas Pantelides, Managing Director of PSE, says: "We are delighted to become part of the Siemens organisation.
Pfizer to Acquire Array BioPharma for $11.4B contractpharma
June 18, 2019
Expands innovative biopharma business with multiple targeted investigational cancer therapies and adds a large portfolio of royalty-generating medicines.
Lonza Launches Engine Equipment Portfolio contractpharma
June 12, 2019
New offering aims to address the entire small molecule drug development process.
AbbVie expands immunology portfolio in the U.S. with FDA approval of SKYRIZI™ biospectrumasia
April 28, 2019
AbbVie recently received approval of SKYRIZI from the Japanese Ministry of Health, Labour and Welfare (MHLW) for the treatment of plaque psoriasis, generalized pustular psoriasis, erythrodermic psoriasis and psoriatic arthritis
Dr. Reddy's Laboratories Announces Acquisition of ANDA Portfolio firstwordpharma
April 15, 2019
Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as ……

Previous page 1 2 Next page